tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market

Crispr Therapeutics AG (CRSP) Technical Analysis

Compare
9,081 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is -0.63, suggesting Crispr Therapeutics AG is a Buy.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 42.84, while Crispr Therapeutics AG’s (CRSP) share price is $42.62, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 43.44, while Crispr Therapeutics AG’s (CRSP) share price is $42.62, making it a Sell.

Crispr Therapeutics AG (CRSP) Pivot Points

Mar 25, 2025, 11:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
39.26
39.83
40.53
41.10
41.80
42.37
43.07
Fibonacci
39.83
40.32
40.62
41.10
41.59
41.89
42.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Mar 25, 2025, 11:26 AM
Period
Simple
Exponential
MA5
41.58Buy
41.93Buy
MA10
42.07Buy
42.24Buy
MA20
42.95Sell
42.84Sell
MA50
42.93Sell
43.44Sell
MA100
44.87Sell
44.77Sell
MA200
48.18Sell
48.46Sell
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 42.24, while Crispr Therapeutics AG’s (CRSP) share price is $42.62, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 44.77, while Crispr Therapeutics AG’s (CRSP) share price is $42.62, making it a Sell.
Crispr Therapeutics AG’s (CRSP) stock price is $42.62 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 42.93, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $42.62 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 44.87, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $42.62 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 48.18, creating a Sell signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Mar 25, 2025, 11:26 AM
Name
Value
Implied Action
RSI (14)
48.59
Neutral
STOCH (9,6)
29.92
Neutral
STOCHRSI (14)
22.40
Neutral
MACD (12,26)
-0.63
Buy
ADX (14)
11.38
Buy
Williams %R
-60.84
Buy
CCI (14)
-43.06
Neutral
ATR (14)
2.37
-
Ultimate Oscillator
48.66
Neutral
ROC
-1.91
Sell
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 48.59, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 11.38, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is -43.06, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is -1.91, creating a Sell signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Sell.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 48.59, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is -0.63, which suggests CRSP is a Buy.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 41.58, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 42.95, which suggests CRSP is a Sell.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 42.93, which suggests CRSP is a Sell.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 48.18, which suggests CRSP is a Sell.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -60.84, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is -43.06, which suggests CRSP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis